JJC:   I'm just trying to preserve cash in the toughest market I've seen in years... Holy cow, down-237 DOW points today...  Another chaotic day led down by our foes, the financials... Again, despite that decline, led by the two stooges, Fannie Mae (FNM) and Freddie Mac (FRE), I am urging you in as strong a fashion as I can, that you not bottom fish that group... Today was the worst day for the financials, that's the banks, the brokers, in six years... And the blood-letting is not over...

With our economy struggling under the weight of multiple potential bank failures, with high oil prices... Hey, listen, high fuel prices, I mean, you name it... How about strangling individuals and companies alike... You need the Cramerican Marine Field Guide to Recessions... That is, if you want to make some money, or at least hold your own in this miserable, horrible market... We don't mince words... The field guide, available at Amazon for $295, or you could just get Stay Mad For Life, which is much cheaper...

Uh, what it's been highlighting all week is simple... The guide recommends to own stocks that are better assured to have better year over year earnings, even if those earnings comparisons will be less than you might see short term, from those one time flyers, the steels or oils or minerals... The one times queens of the runway... Look at this, it's interesting... I open the American field guide and it's Right to Wills and Testaments... Well, I mean, just a second... I mean people are getting killed, but I don't mean it literally... Anyway, this field guide is a way to avoid being mauled by the growling, prowling bears in our midst, and I do not mean Yogi and Boo Boo... Now that earning season has started, the area I like, the area that the field guide says you can buy at this point, is healthcare... And as I've explained before, this has nothing to do with healthcare companies doing better... That's right, they're not doing better than expected... The fundamentals matter when I pick stocks on Mad Money, but they're not the reason we're rotating in to healthcare... This is all about Wall Street's fashion show... Where as before, when we weren't facing the possibility of a worldwide slow down, the big money guys could comfortably invest in more exciting, fast-growing, less consistent stocks... Fertilizer... Okay?... I know, it doesn't sound very exciting... But it was... Well, the big money guys are now afraid that the companies behind those stocks won't be able to make the huge estimates that they're also expecting for next year... Not if there's a global slow down... The healthcare stocks, on the other hand, are boring, they're consistent, and they're immunized against everything that is keeping this market down and forcing it lower... No bad mortgage loans here... That means that these are the kinds of stocks that let big money managers and you sleep comfortably at night... These are definitive, Mad Money, lovey blanket stories... I love a good lovey blanket, as anybody knows, because my old nick name was ah baby, not kidding... Anyway, we want to get in before the institutional investors take these stocks up too much, although that's already started happening, coincident to this week's Mad Money series... The Cramerican Marine Field Guide to Recessions so far has led me to recommend Genentech Inc. (DNA) and Smith & Nephew PLC (SNN)...

So today let me give you a new one all right?... And look, you can buy them right into the teeth of the sell off... These work in the sell off and the answer is...

The stock I give you today is Becton Dickinson & Co. (BDX)...

BDX is not to be confused with Emily Dickinson, which I know not from reading Oprah's books, but because it's the rest stop for the cleanest bathrooms on the Jersey Turnpike...

The BDX makes syringes and needles... But, also caters and various other day to day medical devices like surgical blades, disposable containers, I told you it was boring, as well as having a nice diagnostics division... I especially like diagnostics division if the polls are right and we get an Obama administration, because his healthcare plans specifically targets spending more money on preventative medicine... And when I hear that, I think diagnostics, and therefore, I think BDX...

Now, way, way, way back on April 30th of last year, I devoted a segment to the three B's... No relation to the company and the Constant Gardener, if anyone remembers that movie... BDX, along with Baxter International Inc. (BAX), and CR Bard Inc. (BCR), not to confused with the bard, to buy or not to buy, not a question... In that same show we mixed even more metaphors and ensued great confusion by invoking another three B's... Brahms, Beethoven and Bach, that was a failed gambit to bring back the 9-year-old demographic...

So far, BDX has been the worst performer of the three, which means, it's come front and center again... It's only up about 3%, CR Bard is up just under 6%... Baxter, is around 15% higher from when I recommended it... And the market's done terribly... Now I have to tell you, I don't like Baxter anymore... That's a big change, just for tonight, okay?... I am saying sell, sell, sell Baxter right here, okay?... So I suggest if you own any, take profits in that name... This is a special Wednesday night edition of Thursday's Sell Block, kind of like a special Thursday night edition of Monday Night Football... Now I recommend that you take your Baxter profits, and plow them into my new favorite of the three B's, BDX... BDX is less dependent on the US, it's a rest of worlder, with 55% of its sales coming from the rest of the world... But it's also making good money in this country, at least in part because of legislative mandates here calling for the use of syringes with extra safety features that prevent the people from, the people they use on from contracting diseases... Safety, right?... BDX is a big seller of these so called shielded needles... Just think of them as the safer, cleaner needle alternative... For the much coveted junky demographic, know this stock is for you... By the way, I don't want to disparage Bard at all, by the way, Bard is good too... I just saying take your money out of Baxter, alright?... Germany and Spain have recently worked in similar mandates, so I think BDX can expect to sell more of its pricier shielded needles in these countries too... They can give you even cleaner needles, it's just catching on... You know, most of the world, including Europe, other than Spain and Germany, hasn't made a push for clean needles?... But when these countries do, I think they will go for the expensive needle... It seems like a small price to pay for reduced risk of infecting people with diseases, and that's going to mean more money for BDX... I don't care how bad the economy gets, and it's getting bad worldwide, doctors just aren't going to stop using syringes... How about this diagnostics business?... Which we really like... BDX is one of the top providers of tests for MRSA, that's a treatment resistant skin infections, that's the most common cause of skin irritations for people who go to the emergency room in this country... BDX also picked up a great test for Cedephacil, that's a type of Colitis that is expected to be the next major bug in hospital associated infections...

When it bought that Genome back in 2006 we liked that on the show... There could as many as 250,000 to 300,000 people in America with this disease... BDX has got the answer... Now, I think BDX's stock has taken a beating for all of the wrong reasons... It's fallen from its 52-week high of $93 in January to $81 today... And I think of it... Look, I know, I've talked to the people pushing it down and selling it... They're all worried about higher oil prices... Resin, which BDX uses to manufacture most of its products, makes up around 9% of BDX's cost of good sole... For every dollar increase of the price of oil, the price of Resin, which is made from oil, goes up 40 cents... I think the Street's been making a mountain out of a molehill here... Like the spray makeup that does that to this pimple, right here... Anyway, I think their treating a medical company as a chemical company is just a big mistake... I also believe that oil seems to have hit a Cramerican road block at $150, remember, that was our price target for oil... And I think that it's starting to, frankly, boost a lot of other companies that use a lot more oil than BDX, like Procter & Gamble (PG), that's rosy you should be transferring to BDX right now... Particularly because management assured me when I was on Squawk Box last month, when BDX reported, that raw costs woes were way over the top, versus the reality for BDX.

.  .  .  .  .